Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer.
about
Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis BAlpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis BContribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaA concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinomaHepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveNanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaSurveillance for hepatocellular carcinoma.Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringCurrent management of hepatocellular carcinoma.Cost-effectiveness of liver cancer screening in adults at high risk for liver cancer in the republic of Korea.Recent developments in the first detection of hepatocellular carcinomaEconomic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base.APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review.Hepatocellular carcinoma: From diagnosis to treatment.NCCN clinical practice guidelines in oncology: hepatobiliary cancersDevelopment of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal ModelHepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma.Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinomaCost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial resultsUse of Biomarkers in Screening for Cancer.Perspectives of physicians regarding screening patients at risk of hepatocellular carcinoma.Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?Hepatocellular carcinoma: diagnostics and screening.Update on biomarkers of hepatocellular carcinoma.The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma.Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.High expression of GNA13 is associated with poor prognosis in hepatocellular carcinomaControversies in surveillance and early diagnosis of hepatocellular carcinoma.Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation.
P2860
Q24200785-DD9E37E1-525C-4560-B8C0-546610030A08Q24248748-614CC917-EE12-457B-9BD2-64A38540448DQ26740332-39FDFFB4-E53F-4A62-AF7C-3CB5977A6C9EQ26752478-F5676837-E2C9-458E-89B9-9C92A40BA41FQ26766707-3F19AA5D-6174-4A14-971E-5149CEBE2B90Q26767217-AE3F84D6-3BF5-45DC-944A-F1666E4C67C1Q26823523-9F1E4300-CAB8-4007-9EA4-FF09B92E4BD4Q27690269-9C7E1DE8-C226-4E0E-B386-420268DE18EEQ30151390-2870693B-E85A-4E46-8CB0-6A7A3D98DDDDQ30436747-CE9EC50C-E1D0-4A56-A67D-5CC0F8F0407BQ33582165-4D1623FA-CF12-4A2D-BEDE-7AFF4AD7A7EDQ34043444-889A5D57-BB44-4E9C-B4A8-58FB1CA924B9Q34055894-F0F87370-A02D-423C-9186-ABCA85F276A1Q34682037-2E91FE4C-E851-4E55-91B7-18895783ADBAQ35207736-9F6106C8-4D2B-45DF-8E19-E8379BB148ACQ35446607-93CA213C-CA5C-4B27-AB8F-5507E4485967Q35668716-EFF34FA1-7B0E-4698-BEEA-C6F1A5B463AAQ35703937-B465D43C-FEB1-4ACA-9CF3-058E795D7011Q35926191-1AEBF0AC-3378-40E4-B904-72AE66C352F0Q36079127-F4471CD7-A082-431C-9B89-3142B29BF092Q36272668-8AFC28F0-EE20-4A6B-B913-D0616CD69E2CQ36347633-C8632315-B244-402C-B0AC-5EFF4F6913DDQ36349931-3D0433EF-BCCA-4EFF-A527-DEE512A1A871Q36375646-7269DA12-597A-4D6A-AF99-34933753DCDEQ36724410-2AD03385-961E-4433-BD70-4F818528B84EQ37003878-3461ED5B-2D1E-4A13-8396-FDF41453952FQ37155019-EDDF9751-D615-470D-A3BF-F3959FF23C95Q37158120-3A1410E2-3001-4634-B9EC-BFBB6AA2AD08Q37350320-BF04874B-40C1-499A-B0A6-ECF7A85344EAQ37356370-DA35C8E3-51AD-4A3A-BA1C-877E6240CF4BQ37408912-94C9DD4F-E21C-4237-92AD-2134D2B9F385Q37813192-1C33AE2F-F919-4B84-8EF9-5791C4C56776Q38166133-7FFBF73F-055B-499A-9802-64E2489B0FF1Q38217657-0875DD60-70B9-449A-B4D7-33A0FE16E0B2Q41565833-5BED222C-AC92-4EB5-8A2F-71FCEAF9125FQ41817486-3F093D97-C031-44BB-9702-6B302E950C4FQ42363972-733254A0-AC27-4F9F-B66D-E1C5A912653CQ43047082-85EEB59E-124D-4BEC-9D38-5A8CCC93E472Q44902518-E697D286-1985-4337-906F-B79A3D1531FCQ46964114-941A8D50-0F7A-446E-911F-AB718F141D87
P2860
Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@ast
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@en
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@nl
type
label
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@ast
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@en
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@nl
prefLabel
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@ast
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@en
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@nl
P356
P1476
Combined alpha fetoprotein tes ...... test for primary liver cancer.
@en
P304
P356
10.1136/JMS.6.2.108
P577
1999-01-01T00:00:00Z